Michael Schaeffer
Director/Board Member bei VIVORYON THERAPEUTICS N.V.
Vermögen: - $ am 31.03.2024
Profil
Dr. Michael Schaeffer is an Executive Director & Chief Business Officer at Vivoryon Therapeutics NV.
He is on the Board of Directors at Vivoryon Therapeutics NV.
Dr. Schaeffer was previously employed as a Chief Executive Officer & Managing Director by Crelux GmbH and a Chief Executive Officer & Managing Director by SiREEN AG.
He received his doctorate degree from Ludwig-Maximilians-Universität München.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Michael Schaeffer
| Unternehmen | Position | Beginn |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Director/Board Member | - |
Ehemalige bekannte Positionen von Michael Schaeffer
| Unternehmen | Position | Ende |
|---|---|---|
Crelux GmbH
 Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Chief Executive Officer | 01.03.2016 |
| SiREEN AG | Chief Executive Officer | 01.01.2004 |
Ausbildung von Michael Schaeffer
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VIVORYON THERAPEUTICS N.V. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| SiREEN AG | Commercial Services |
Crelux GmbH
Crelux GmbH BiotechnologyHealth Technology Crelux GmbH provides structure based drug discovery solutions. The firm provides customized services to support hit-finding, conformational analysis and lead optimization, including protein production, biophysical assays, fragment screening, and X-ray crystallography. It works for pharma, biotech and research organizations. The company was founded by Ismail Moarefi, Martin Ried and Michael Schaeffer and is headquartered in Martinsried, Germany. | Health Technology |
